LEVERONE JASON A. (Chief Financial Officer) received a stock award from ONKURE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/8/2024ACC: 0001415889-24-024918
Officer· Chief Financial Officer
Since Oct 2024
+158.04K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
158.04K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+16.33K
Price / share
—
Trade value
—
% of position
New position
10/4/2024
0.00→16.33K
Total
Net shares
+16.33K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 10/4/2024 | A · Award | +16.33K | — | — | New position | 0.00 | 16.33K |
| Total | +16.33K | $0.00 | ||||||
Derivative Transactions3
Employee Stock Option (right to buy)
Direct
Converts to
Class A Common Stock
5.78K shares
Shares
+5.78K
Strike price
21.20
Held after
5.78K
Exercisable
—
10/4/2024
Employee Stock Option (right to buy)
Direct
Converts to
Class A Common Stock
5.32K shares
Shares
+5.32K
Strike price
13.99
Held after
5.32K
Exercisable
—
10/4/2024
Employee Stock Option (right to buy)
Direct
Converts to
Class A Common Stock
130.61K shares
Shares
+130.61K
Strike price
18.20
Held after
130.61K
Exercisable
—
10/4/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Class A Common Stock5.78K shares | 10/4/2024 | A · Award | +5.78K | 21.20 | — | 5.78K |
| Employee Stock Option (right to buy) Direct | Class A Common Stock5.32K shares | 10/4/2024 | A · Award | +5.32K | 13.99 | — | 5.32K |
| Employee Stock Option (right to buy) Direct | Class A Common Stock130.61K shares | 10/4/2024 | A · Award | +130.61K | 18.20 | — | 130.61K |